• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

    123.88 -1.44 (-1.15%)
    Streaming Delayed Price Updated: 10:36 AM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about iRhythm Holdings, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
    From iRhythm
    Via GlobeNewswire
    News headline image
    The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
    Issued on behalf of VentriPoint Diagnostics Ltd. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Holdings Appoints Jason Patten to its Board of Directors
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
    From iRhythm
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From iRhythm
    Via GlobeNewswire
    News headline image
    From Hype to P&L: Hospitals Now Buying AI That Pays
    ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
    From iRhythm
    Via GlobeNewswire
    News headline image
    Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Technologies to Participate in Upcoming Investor Conferences
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Technologies Announces Third Quarter 2025 Financial Results
    From iRhythm
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
    From iRhythm
    Via GlobeNewswire
    News headline image
    IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Technologies to Participate in Upcoming Investor Conferences
    From iRhythm
    Via GlobeNewswire
    News headline image
    AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Technologies Announces Second Quarter 2025 Financial Results
    From iRhythm
    Via GlobeNewswire
    News headline image
    IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
    From iRhythm
    Via GlobeNewswire
    News headline image
    iRhythm Technologies Announces Board Member Retirements and New Director Appointments
    From iRhythm
    Via GlobeNewswire
    News headline image
    Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
    EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    News headline image
    IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
    Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major... 
    From iRhythm
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.